Norgine France News and Activities

Norgine France is owned by Norgine. Norgine has a direct presence in 3 countries.

Acquisition, funding and merger involving Norgine.

• Norgine has just announced a $67 Million fundraising (posted on March 26 2026).

View the org chart displaying its 7 main executives

Most searched biographies at Norgine France

• Cyril Tavier, General Manager
• Léa Furlan, Director of Human Resources
• Valérie Cohen-Smadja, Head of Commercial

Popular executive movements at Norgine France

• Valérie Cohen-Smadja, who was National Sales Director, is promoted to Head of Commercial  (posted on March 26 2026).

Create your alert
to follow the executive moves at Norgine France.

Norgine has 1,914 competitors including Sanofi (France), Moderna (United States (USA)) and Eli Lilly (United States (USA)).

Popular M&A news in Pharmaceuticals

• Aurobindo has announced the acquisition of Lannett  (posted on June 26 2026).
• Merck has announced the acquisition of Bio-Techne  (posted on June 25 2026).
• Eli Lilly has acquired Centessa Pharmaceuticals (posted on June 24 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• David Ricks - President, Chief Executive Officer and Chairman of the Board at Eli Lilly
• Richard Saynor - Chief Executive Officer at Sandoz

Learn more about the Pharmaceuticals industry

Press releases by Norgine France

• Norgine B.V. submits Marketing Authorisation Application via Project Orbis for eflornithine (difluoromethylornithine [DFMO]) in high-risk neuroblastoma - Norgine
• Norgine receives positive CHMP opinion recommending approval of NPJ5008 (dantrolene sodium hemiheptahydrate) for the treatment of malignant hyperthermia - Norgine
• Norgine Announces Appointment of New CEO Janneke van der Kamp - Norgine
• Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand - Norgine
• Pedmarqsi® (anhydrous sodium thiosulfate) recommended by NICE for patients 1 month to 17 years of age in England and Wales for the prevention of cisplatin-induced hearing loss - Norgine
• European study highlights need to improve the quality of conversations about induction of labour (IoL) in  clinical settings - Norgine
• Norgine Strengthens Senior Leadership with the Appointment of Saulo Martiniano as Chief Operating Officer - Norgine
• NORGINE LAUNCHES ZIVEREL® IN AUSTRIA, BELGIUM, LUXEMBOURG AND SWITZERLAND - NorgineNORGINE LAUNCHES ZIVEREL® IN AUSTRIA, BELGIUM, LUXEMBOURG AND SWITZERLAND - Norgine
• LYMPHOSEEK®▼ (99mTc-tilmanocept) LAUNCHES IN EUROPE - NorgineLYMPHOSEEK®▼ (99mTc-tilmanocept) LAUNCHES IN EUROPE - Norgine
• NORGINE B.V. ACQUIRES AZANTA A/S, STRENGTHENING ITS POSITION AS A LEADING EUROPEAN SPECIALIST PHARMACEUTICAL COMPANY - NorgineNORGINE B.V. ACQUIRES AZANTA A/S, STRENGTHENING ITS POSITION AS A LEADING EUROPEAN SPECIALIST PHARMACEUTICAL COMPANY - Norgine
• View more press releases Close

Social media about Norgine France

• Norgine France on Wikipedia, Google News & Yahoo Finance
• Norgine France on LinkedIn, X (Twitter) & YouTube